These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17180595)

  • 1. Evaluation of neuropsychological performance of HIV-infected patients with minor motor cognitive dysfunction treated with highly active antiretroviral therapy.
    Carvalhal AS; Rourke SB; Belmonte-Abreu P; Correa J; Goldani LZ
    Infection; 2006 Dec; 34(6):357-60. PubMed ID: 17180595
    [No Abstract]   [Full Text] [Related]  

  • 2. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
    Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
    Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.
    Vitiello B; Goodkin K; Ashtana D; Shapshak P; Atkinson JH; Heseltine PN; Eaton E; Heaton R; Lyman WD
    AIDS; 2007 Jul; 21(11):1415-22. PubMed ID: 17589187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HIV Dementia Scale: predictive power in mild dementia and HAART.
    Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR
    J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus encephalopathy: cognitive and radiologic improvement after antiretroviral therapy.
    Silva MT; Wagner S; Grinsztejn B
    Arch Neurol; 2009 Aug; 66(8):1040-1. PubMed ID: 19667231
    [No Abstract]   [Full Text] [Related]  

  • 6. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
    Schifitto G; Navia BA; Yiannoutsos CT; Marra CM; Chang L; Ernst T; Jarvik JG; Miller EN; Singer EJ; Ellis RJ; Kolson DL; Simpson D; Nath A; Berger J; Shriver SL; Millar LL; Colquhoun D; Lenkinski R; Gonzalez RG; Lipton SA; ; ;
    AIDS; 2007 Sep; 21(14):1877-86. PubMed ID: 17721095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.
    Mellgren A; Price RW; Hagberg L; Rosengren L; Brew BJ; Gisslén M
    Neurology; 2007 Oct; 69(15):1536-41. PubMed ID: 17923616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.
    Robinson-Papp J; Byrd D; Mindt MR; Oden NL; Simpson DM; Morgello S;
    Arch Neurol; 2008 Aug; 65(8):1096-101. PubMed ID: 18695060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV, the brain, children, HAART and 'neuro-HAART': a complex mix.
    Brew BJ
    AIDS; 2009 Sep; 23(14):1909-10. PubMed ID: 19550290
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 RNA levels in cerebrospinal fluid and plasma correlate with AIDS dementia.
    Hengge UR; Brockmeyer NH; Esser S; Maschke M; Goos M
    AIDS; 1998 May; 12(7):818-20. PubMed ID: 9619817
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.
    McCutchan JA; Wu JW; Robertson K; Koletar SL; Ellis RJ; Cohn S; Taylor M; Woods S; Heaton R; Currier J; Williams PL
    AIDS; 2007 May; 21(9):1109-17. PubMed ID: 17502721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism in hiv-infected patients on highly active antiretroviral therapy.
    Tisch S; Brew B
    Neurology; 2009 Aug; 73(5):401-3. PubMed ID: 19652146
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired neurocognition in HIV-infected patients: antecedents and treatment.
    Fessel WJ
    AIDS; 2009 Aug; 23(13):1731-3. PubMed ID: 19574882
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurocognitive outcomes in pediatric HIV.
    Willen EJ
    Ment Retard Dev Disabil Res Rev; 2006; 12(3):223-8. PubMed ID: 17061290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex.
    Brew BJ
    AIDS; 2004 Jan; 18 Suppl 1():S75-8. PubMed ID: 15075501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment: treatment of HIV-associated cognitive impairment--beyond HAART.
    Parsons TD; Robertson KR
    AIDS Read; 2005 Jun; 15(6):293. PubMed ID: 15962452
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy.
    Lindsey JC; Malee KM; Brouwers P; Hughes MD;
    Pediatrics; 2007 Mar; 119(3):e681-93. PubMed ID: 17296781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.